BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23151075)

  • 21. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.
    Varma AR; Adams W; Lloyd JJ; Carson KJ; Snowden JS; Testa HJ; Jackson A; Neary D
    Acta Neurol Scand; 2002 Apr; 105(4):261-9. PubMed ID: 11939938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher Aortic Stiffness Is Related to Lower Cerebral Blood Flow and Preserved Cerebrovascular Reactivity in Older Adults.
    Jefferson AL; Cambronero FE; Liu D; Moore EE; Neal JE; Terry JG; Nair S; Pechman KR; Rane S; Davis LT; Gifford KA; Hohman TJ; Bell SP; Wang TJ; Beckman JA; Carr JJ
    Circulation; 2018 Oct; 138(18):1951-1962. PubMed ID: 30018169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.
    Camargo A; Wang Z;
    J Alzheimers Dis; 2021; 81(4):1727-1735. PubMed ID: 33967053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease.
    Yoshiura T; Hiwatashi A; Yamashita K; Ohyagi Y; Monji A; Takayama Y; Nagao E; Kamano H; Noguchi T; Honda H
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1388-93. PubMed ID: 19342545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative measurement of cerebral haemodynamics in early vascular dementia and Alzheimer's disease.
    Bateman GA; Levi CR; Schofield P; Wang Y; Lovett EC
    J Clin Neurosci; 2006 Jun; 13(5):563-8. PubMed ID: 16540327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasonographic measurement of cerebral blood flow, cerebral circulation time and cerebral blood volume in vascular and Alzheimer's dementia.
    Schreiber SJ; Doepp F; Spruth E; Kopp UA; Valdueza JM
    J Neurol; 2005 Oct; 252(10):1171-7. PubMed ID: 16151603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different post label delay cerebral blood flow measurements in patients with Alzheimer's disease using 3D arterial spin labeling.
    Liu Y; Zeng X; Wang Z; Zhang N; Fan D; Yuan H
    Magn Reson Imaging; 2015 Nov; 33(9):1019-1025. PubMed ID: 26113261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia.
    Lojkowska W; Ryglewicz D; Jedrzejczak T; Minc S; Jakubowska T; Jarosz H; Bochynska A
    J Neurol Sci; 2003 Dec; 216(1):119-26. PubMed ID: 14607313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates.
    Waldemar G; Christiansen P; Larsson HB; Høgh P; Laursen H; Lassen NA; Paulson OB
    J Neurol Neurosurg Psychiatry; 1994 Dec; 57(12):1458-65. PubMed ID: 7798973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer's disease subjects.
    Chau ACM; Cheung EYW; Chan KH; Chow WS; Shea YF; Chiu PKC; Mak HKF
    Neuroimage Clin; 2020; 27():102302. PubMed ID: 32521474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease.
    Sheng M; Lu H; Liu P; Li Y; Ravi H; Peng SL; Diaz-Arrastia R; Devous MD; Womack KB
    J Alzheimers Dis; 2017; 60(4):1351-1364. PubMed ID: 29036811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic aspects of Alzheimer's disease.
    Nagata K; Sato M; Satoh Y; Watahiki Y; Kondoh Y; Sugawara M; Box G; Wright D; Leung S; Yuya H; Shimosegawa E
    Ann N Y Acad Sci; 2002 Nov; 977():391-402. PubMed ID: 12480778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral blood flow and vasoreactivity in aging: an arterial spin labeling study.
    Leoni RF; Oliveira IA; Pontes-Neto OM; Santos AC; Leite JP
    Braz J Med Biol Res; 2017 Mar; 50(4):e5670. PubMed ID: 28355354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of vascular dementia and Alzheimer disease: a functional transcranial Doppler ultrasonographic study.
    Asil T; Uzuner N
    J Ultrasound Med; 2005 Aug; 24(8):1065-70. PubMed ID: 16040820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous arterial spin labeling cerebral blood flow and morphological assessments for detection of Alzheimer's disease.
    Dashjamts T; Yoshiura T; Hiwatashi A; Yamashita K; Monji A; Ohyagi Y; Kamano H; Kawashima T; Kira J; Honda H
    Acad Radiol; 2011 Dec; 18(12):1492-9. PubMed ID: 21907599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of CO2 in air versus carbogen for the measurement of cerebrovascular reactivity with magnetic resonance imaging.
    Hare HV; Germuska M; Kelly ME; Bulte DP
    J Cereb Blood Flow Metab; 2013 Nov; 33(11):1799-805. PubMed ID: 23921896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral blood flow patterns in Binswanger's disease: a SPECT study using three-dimensional stereotactic surface projections.
    Hanyu H; Shimuzu S; Tanaka Y; Takasaki M; Koizumi K; Abe K
    J Neurol Sci; 2004 May; 220(1-2):79-84. PubMed ID: 15140610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classifying cognitive impairment based on the spatial heterogeneity of cerebral blood flow images.
    Shirzadi Z; Stefanovic B; Mutsaerts HJMM; Masellis M; MacIntosh BJ;
    J Magn Reson Imaging; 2019 Sep; 50(3):858-867. PubMed ID: 30666734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment.
    Urbanova BS; Schwabova JP; Magerova H; Jansky P; Markova H; Vyhnalek M; Laczo J; Hort J; Tomek A
    J Alzheimers Dis; 2018; 63(2):465-477. PubMed ID: 29614647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.